Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-75,418
Closed -$5.17M – 1008
2021
Q4
$5.17M Sell
75,418
-18,928
-20% -$1.33M 0.05% 194
2021
Q3
$7.13M Buy
+94,346
New +$8.08M 0.06% 163
2020
Q4
– Sell
-12,500
Closed -$759K – 616
2020
Q3
$759K Sell
12,500
-6,250
-33% -$397K 0.02% 241
2020
Q2
$1.24M Buy
+18,750
New +$1.19M 0.03% 258

Other funds holding ITRI

UBS O'Connor's ITRI Position: Q1 2022 in Review

UBS O'Connor sold out of Itron (ITRI) in Q1 2022, closing a stake of 75,418 shares — an estimated $5.17M sold.

UBS O'Connor first reported a position in ITRI in Q2 2020 and held it in 4 quarters. The position peaked at $7.13M in Q3 2021. 264 funds tracked by Wall St. Rank hold ITRI as of Q1 2022.

  • UBS O'Connor reported no remaining Itron position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 75,418 Itron shares in Q1 2022, an estimated $5.17M.
  • UBS O'Connor first reported a position in Itron in Q2 2020 and held it in 4 quarters.
  • UBS O'Connor's Itron position peaked at $7.13M in Q3 2021.
  • 264 funds tracked by Wall St. Rank held Itron as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.